Related Experiment Video

Updated: May 29, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Targeting AMPK in the treatment of malignancies

Eliza Vakana1, Jessica K Altman, Leonidas C Platanias

  • 1Robert H. Lurie Comprehensive Cancer Center and Division of Hematology/Oncology, Northwestern University Medical School and Jesse Brown VA Medical Center, Chicago, Illinois 60611, USA.

Journal of Cellular Biochemistry
|September 20, 2011
PubMed

Insights

The AMP-activated protein kinase (AMPK) pathway regulates cell energy and metabolism. AMPK activators show potential as anti-cancer agents by suppressing tumor growth and proliferation.

Area of Science:

  • Cellular metabolism
  • Cancer biology
  • Molecular signaling pathways

Background:

  • The AMP-activated protein kinase (AMPK) pathway is a crucial cellular energy sensor involved in metabolic regulation.
  • AMPK plays significant roles in both normal and malignant cells, influencing key cellular processes.
  • It interacts with the mTOR pathway, regulating mRNA translation and autophagy initiation.

Purpose of the Study:

  • To explore the regulatory roles of the AMPK pathway in normal and malignant cells.
  • To investigate the potential of AMPK activators as anti-cancer therapeutics.
  • To better understand the mechanisms controlling AMPK activity and its effects in cancer.

Main Methods:

  • Literature review on AMPK pathway functions.
  • Analysis of studies on AMPK activators and their effects on mTOR signaling.
  • Examination of research on AMPK's role in cell proliferation and malignant transformation.

Main Results:

  • AMPK activators suppress mTOR activity.
  • AMPK inducers demonstrate negative control over malignant transformation.
  • AMPK activation inhibits cell proliferation in various cancer types.

Conclusions:

  • The AMPK pathway is a key regulator of cellular energy homeostasis and metabolism.
  • AMPK activators hold significant promise as antineoplastic agents.
  • Further research is warranted to fully elucidate AMPK's mechanisms in cancer therapy.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...